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ABSTRACT
Ubiquitin ligase Smurf1-deficient mice develop an increased-bone-mass phenotype in an age-dependent manner. It was reported that
such a bone-mass increase is related to enhanced activities of differentiated osteoblasts. Although osteoblasts are of mesenchymal stem
cell (MSC) origin and MSC proliferation and differentiation can have significant impacts on bone formation, it remains largely unknown
whether regulation of MSCs plays a role in the bone-mass increase of Smurf1-deficient mice. In this study we found that bone marrow
mesenchymal progenitor cells from Smurf1
 /  mice form significantly increased alkaline phosphatase–positive colonies, indicating roles
of MSC proliferation and differentiation in bone-mass accrual of Smurf1
 /  mice. Interestingly, Smurf1
 /  cells have an elevated protein
level of AP-1 transcription factor JunB. Biochemical experiments demonstrate that Smurf1 interacts with JunB through the PY motif and
targets JunB protein for ubiquitination and proteasomal degradation. Indeed, Smurf1-deficient MSCs have higher proliferation rates,
consistent with the facts that cyclin D1 mRNA and protein both are increased in Smurf1
 /  cells and JunB can induce cyclinD1 promoter.
Moreover, JunB overexpression induces osteoblast differentiation, shown by higher expression of osteoblast markers, and JunB knock-
down not only decreases osteoblast differentiation but also restores the osteogenic potential to wild-type level in Smurf1
 /  cells.
In conclusion, our results suggest that Smurf1 negatively regulates MSC proliferation and differentiation by controlling JunB turnover
through an ubiquitin-proteasome pathway.  2010 American Society for Bone and Mineral Research.
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Introduction
S
keletal homeostasis determines bone mass in adults by
achieving balance between bone resorption by osteoclasts
and bone formation by osteoblasts.
(1) Thus the number and
activities of both osteoclasts and osteoblasts must be tightly
regulated to ensure proper development and maintenance
of the skeletal system. Because osteoblasts are mesenchyme-
originated cells, their formation isinfluencedby the regulation of
mesenchymal stem cell (MSC) commitment and differentiation
potential. For example, osteoblastic transcription regulator
Runx2 is specifically expressed in MSCs prefiguring the skeleton
at E10.5.
(2,3) Therefore, it is important to study how MSCs commit
to osteoblast precursors to obtain clues to curing bone diseases
such as osteoporosis.
Smurf1 was identified as a homologous to the E6-AP carboxyl
terminus (HECT)-type ubiquitin ligase that was demonstrated to
target Smad1,
(4) Smad5,
(5) Runx2,
(6) RhoA,
(7) bone morphoge-
netic protein (BMP) or transforming growth factor b (TGF-b) type
I receptors,
(8,9) MEKK2,
(13) Talin head,
(10) and Prickle 1
(11) for
ubiquitinationanddegradation.InteractionbetweenSmurf1and
its target protein requires WW domains in the Smurf1 and PY
motif of the substrate, a well-known feature of HECT-type
ubiquitin ligases.
(12) The phyisologic role of Smurf1 in vivo is
characterized in Smurf1
 /  mice that display an age-dependent
bone mass increase.
(13) Intriguingly, the increased bone mass in
Smurf1
 /  mice was proposed to be associated with enhanced
osteoblast activities, contributed by activation of the JNK
signaling cascade rather than an accumulation of BMP signaling
factors. Currently available analyses of Smurf1
 /  mice have
been focused on differentiated and mature osteoblasts.
(13,14)
Whether or not Smurf1 affects the function of MSCs or
osteoprogenitors remains to be explored.
In this study we demonstrated that bone marrow stromal cells
derived from adult Smurf1
 /  mice have increased osteogenic
colony formation and a concurrent higher level of JunB protein.
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1246Our work demonstrated that JunB is an ubiquitination substrate
targeted by Smurf1 as well as a stimulator of MSC proliferation
and differentiation into osteoblasts. Therefore, the increased-
bone-mass phenotype of Smurf1
 /  mice could be attributed
to the absence of JunB ubiquitination machinery and the
consequent accumulation of JunB proteins in cells, as evidenced
by our siRNA experiments that restored the osteogenic potential
of Smurf1
 /  cells to the wild-type level. Collectively, our results
suggest that Smurf1 negatively regulates MSC proliferation and
differentiationtoosteoblasts by controllingJunB proteinstability
through ubiquitination and the proteasome pathway.
Materials and Methods
Animals
All animals used in this study, except those used for isolating
calvarial preosteoblasts, were 6 to 10 months old when reduced
bone volume occurred in Smurf1
 /  mice, as described
previously.
(13,14) Smurf1
 /  and wild-type control mice were
from a C57/BL6 background. The Institutional Animal Care and
Use Committee approved all studies.
Plasmids and antibodies
Myc-Smurf1, Myc-Smurf1-C710A, Flag-Smad6, and HA-Ubiquitin
expression vectors were described previously.
(15,16) GST-Smurf1
vector was ordered from Addgene (Cambridge, MA). pMX-JunB-
IRES-EGFP retroviral vector was obtained from Dr K Matsuo
(Tokyo, Japan).
(17) We constructed a Flag-JunB overexpression
vector using p3XFLAG-CMV-7.1 expression vector (Sigma, St
Louis, MO, USA) as the backbone. The tyrosine residue of the
PPVY motif of JunB was mutated into phenylalanine to generate
the JunB-YF mutant using a QuikChange Site-Directed Mutagen-
esis Kit (Stratagene, La Jolla, CA). Monoclonal antibodies specific
for Flag, HA, and b-Actin antibodies were purchased from Sigma;
anti-JunB, anti-c-Jun, and anti-c-Myc antibodies were from Santa
Cruz Biotechnology (Santa Crus, CA, USA); Allophycocyanin
(APC)–anti-CD45.2 wasboughtfrom eBioscience(SanDiego,CA).
Cell cultures and mesenchymal stem cell isolation
Primarycalvarialcellsandbonemarrowstromalcellswereisolated
according to our previously described methods.
(14,16) Cells were
culturedinaminimalessentialmedium(a-MEM)with10%to20%
fetalbovineserum(FBS).ForisolatingMSCs,bonemarrowstromal
cells were cultured in a-MEM plus 20% FBS, and the second to
thirdpassagecellswereused.Cellswereincubatedwithanti-CD45
antibody–conjugated microbeads (Miltenyi Biotec, Auburn, CA).
The CD45-negative (CD45
 ) population was isolated by negative
selection according to the manufacturer’s instructions as MSCs.
Fluorescence-activatedcellsorting(FACS)analysesconfirmedthat
more than 98% of isolated cells were CD45
 .
Colony-forming unit (CFU) assays and cell
proliferation assays
Bone marrow cells were isolated from the femurs of mice, filtered,
seeded as 1 10
7 cells per 15-cm dish in a-MEM plus 15% FBS
with b-glycerophosphate. After 25 to 28 days, cells were fixed in
10% formalin and then subjected to alkaline phosphatase (ALP)
staining and eosin staining. The numbers of ALP
þ and total
colonies (each containing more than 20 cells) were counted. Cell
proliferation assays were performed using CellTiter 96 AQueous
One Solution Cell Proliferation Assay (MTS) from Promega
(Madison, WI). Triplicates were done for each group.
GST pull-down, immunoprecipitation, and
ubiquitination assays
GST pull-down, immunoprecipitation, and ubiquitination assays
GST-Smurf1 protein was expressed in Rosetta2 (DE3) and
Glutathione S-Transferase (GST) fusion proteins were purified as
described previously.
(18) In vitro transcription/translation of JunB
protein was performed using a TNT Coupled Reticulocyte Lysate
System (Promega) with pRK5-JunB as the template according to
the manufacturer’s instruction. Purified GST-Smurf1 proteins were
incubated with in vitro–translated JunB protein at 48Cf o r3h o u r s
and washed with buffer containing 50mM of Tris-HCl, pH 7.4,
150mMofNaCl,0.5%Nonidet P-40,and 10% glycerol threetimes.
The bound protein were resolved by SDS-PAGE analysis and
subjected to Western blotting. For Flag immunoprecipitation (IP),
293T cells were transfected with the indicated plasmids for
48hours, harvested, and lysed in IP buffer containing 50mM of
Tris-HCl, pH 7.4, 150mM of NaCl, 0.5% Nonidet P-40, and 10%
glycerol. Whole-cell lysates were incubated with 1mL of anti-Flag
antibodiesand20mLofproteinG–agarose(Sigma)for3to4hours
at 48C. For endogenous IP, C2C12 cells were lysed in IP buffer and
incubated with JunB antibodies and 20mL of protein G–agarose
(Sigma)for 3to 4hours at48C.The immunoprecipitatesthen were
washed with IP buffer, resuspended in sample buffer, and
subjected to Western blot analysis. For ubiquitination assays, cells
were transfected with HA-ubiquitin, Myc-Smurf1, and either Flag-
JunB or Flag-JunB-YF and treated with MG132 (10mM) for 4hours
before being harvested. Cell lysates were incubated with an anti-
Flag antibody and protein G–agarose (Sigma) overnight at 48C.
The immunoprecipitates were subjected to Western blot analysis
with an anti-HA antibody.
BrdU incorporation
Smurf1
 /  and wild-type mice were labeled in vivo with BrdU
twice by i.p. injection (a 16-hour interval) and euthanized 2hours
after the second injection. Red blood cells were removed from
bone marrow cells of the mice by NH4Cl, and the remaining cells
were stained with APC–anti-CD45.2 and fluorescein isothiocya-
nate (FITC)–anti-BrdU forflow analyses using aFITC Brdu FlowKit
(BD Pharmingen, Sparks, MD) according to the manufacturer’s
instructions. APC–anti-CD45.2 was used for immunofluorescent
staining of cell surface marker CD45.
siRNA
JunB siRNA and control siRNA were purchased from Santa Cruz
Biotechnology.Calvarialcellsweretransfectedusingtransfection
reagent and medium from Santa Cruz Biotechnology according
to the manufacturer’s instructions. MSC transfections were
performed using DharmaFECT 1 (Thermo Scientific, Pittsburgh,
PA) according to the manufacturer’s instructions.
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Data are presented as means SD, and all experiments were
repeated at least twice with similar results. Statistical analyses
were performed with Stat View Statistical Software (SAS, Cary,
NC, USA). Differences between the two groups were compared
using unpaired Student’s t tests, and more than two groups were
compared using one-way ANOVA, followed by a Bonferroni/
Dunnet test. p Values of less than .05 were considered to be
statistically significant.
Results
Bone marrow mesenchymal stromal cells from Smurf1
 / 
mice have increased potential to form osteogenic
colonies
Smurf1
 /  mice develop increased bone mass and osteoblast
activitiesinanage-dependentmanner.
(13)However,itisnotclear
whether such phenotypic changes are related to an alteration in
MSC proliferation and differentiation into osteoblasts. To assess
the proliferation and differentiation potential of MSC osteoblast
lineage, we performed a colony-forming assay using bone
marrow mesenchymal stromal cells from 6- to 10-month-old
Smurf1
 /  and wild-type mice that have developed age-
associated bone loss. Specifically, we cultured bone marrow
mesenchymal stromal cells with osteogenic medium and
measured the number and size of ALP
þ colonies. The CFU
assay results showed that the numbers of both ALP
þ colonies
and total colonies were significantly increased in cells from
Smurf1
 /  mice (Fig. 1A, C). Generally, Smurf1
 /  cells formed
larger colonies than their wild-type counterparts (Fig. 1A, B), and
the percentage of ALP
þ cells within one colony was higher
(Fig. 1B). We also performed real-time quantitative PCR (qPCR) to
examine the expression level of ALP, an important osteoblast
marker gene, and demonstrated that Smurf1
 /  bone marrow
stromal cells had higher ALP expression levels than wild-type
cellswiththesamedurationofosteogenictreatment,suggesting
that osteoblast differentiation occurred earlier in Smurf1
 /  cells
than in wild-type cells under osteogenic culture conditions
(Fig. 1D).
Bone marrow stromal cells contain MSCs that give rise to
osteoblasts on differentiation, a process that consists of multiple
stages and is controlled by important transcription factors
including Runx2 and AP-1 family members.
(1) Since the Smurf1
 / 
phenotype of mesenchymal cell proliferation and differentiation
suggests that the regulation may occur at the early stages of
osteogenesis, we aimed to search for the transcriptional factors
that respond to osteogenic treatment early and intensively. We
treated C2C12 myoblast/osteoblast progenitor cells with bone
morphogenetic protein 2 (BMP2) and examined the expression
levelsofRunx2andJunB,twogenesthatareknowntoparticipate
in early BMP responsiveness.
(19) The expression levels of JunB
mRNA peaked (12-fold) at 1 hour after BMP2 treatment and
returned to 2- to 3-fold thereafter and stayed at that level for the
rest of the time points (Fig. 1E). In addition, Runx2 mRNA started
to increase at 1 hour, peaked at 6hours, and remained at a
relatively high level compared with untreated samples. The
expression of osteocalcin, an important marker gene of mature
osteoblasts, also was examined to confirm that the treatment of
C2C12 cells resulted in osteoblast differentiation (Fig. 1E).
Smurf1 promotes JunB protein degradation in vivo
and in vitro
To determine whether an alteration in JunB expression levels
contributes to the osteoblast phenotype of Smurf1
 /  mice, we
performed Western blot analyses using cell lysates from Smurf1
 / 
bone marrow stromal cells orcalvarial preosteoblasts. The results
showed that the protein levels of JunB were increased in
Smurf1
 /  cells (Fig. 2A, B), whereas the expression levels of JunB
mRNA from the marrow stromal cells were not changed (Fig. 2C),
suggesting that JunB protein levels may be regulated by Smurf1.
Another AP-1 transcription factor, c-Jun, underwent no changes
in both mRNA and protein levels (data not shown; Fig. 2A, B).
Smurf1 is a HECT-type E3 ubiquitin ligase that promotes the
ubiquitination of its target protein through recognizing a PY
motif of the target protein. We found that both human and
mouse JunB proteins contain the PPXY sequence (Supplemental
Fig. 1). To determine whether forced expression of Smurf1
induces JunB protein degradation, we cotransfected Myc-tagged
Smurf1 (M-Smurf1) and Flag-tagged JunB (F-JunB) expression
vectors into 293T cells and performed Western blot analysis to
examine JunB protein levels with or without Smurf1 over-
expression. Significantly, Smurf1 expression reduced JunB
protein levels greatly, whereas the mutant Smurf1 (Smurf1-
C710A), of which ubiquitin ligase function was rendered
catalytically inactive by mutation of cystine 710 to alanine,
could not decrease JunB protein levels (Fig. 2D). Furthermore, we
found thattheSmurf1-inducedJunBproteindecreaseoccursina
dose-dependent manner (Fig. 2D). Since AP-1 factors can be
regulated by mitogen-activated protein kinase (MAPK), we
treated cellswithJNK,Erk,orp38MAPKinhibitors andfound that
the inhibition of MAPKs have no effect on Smurf1-induced JunB
degradation in vitro (Supplemental Fig. 2; and data not shown).
We also performed a cycloheximide decay assay to study
whether the turnover rate of JunB protein was changed by
Smurf1 overexpression. As Fig. 2E, F shows, the half-life of JunB
protein was decreased dramatically in Smurf1-overexpressing
cells; meanwhile, the JunB protein was much more stable when
Smurf1 was not overexpressed.
Smurf1 interacts with JunB through PY motif and induces
its ubiquitination and degradation
Smurf1, like other HECT-type E3 ubiquitin ligases, consists of
N-terminal C2 domain, WW domains, and a catalytic C-terminal
HECT domain. The WW domains of E3 ligases bind the PPXY
motif of a target protein to mediate subsequent ubiquitination
and degradation. To examine whether Smurf1 binds JunB
proteins in a direct manner, we performed the GST pull-down
assay using purified GST-Smurf1 protein and in vitro translated
JunB protein. The pull-down results showed that JunB protein
can be copurified with GST-Smurf1 (Fig. 3A), indicating a direct
interaction between Smurf1 and JunB. We also confirmed that
Smurf1-JunB interaction occurs in C2C12 myoblast/osteoblast
1248 Journal of Bone and Mineral Research ZHAO ET AL.progenitor cells by IP of both Smurf1 and JunB proteins using
anti-JunB antibodies (Fig. 3B). To examine whether Smurf1
interacts with JunB through the WW-PPXY interface, we
generated a JunB mutant in which the PPVY motif in JunB
protein was mutated to PPVF using a PCR-based site-directed
mutagenesis method, resulting in a mutant named JunB-YF
(Fig. 3C). Then we used IP assays to examine the bindings of
Smurf1 to wild-type JunB and the JunB-YF mutant. Since Smurf1-
C710A has greater stability than wild-type Smurf1 and the C710A
mutation does not impair the protein-protein interaction
domains, Smurf1-C710A was used in the IP assays. Wild-type
JunB, but not JunB-YF, can be immunopurified with Smurf1,
indicating that Smurf1 binds JunB directly through the
PPVY motif of JunB protein (Fig. 3D). Compared with wild-type
Fig. 1. Smurf1
 /  mice have increased bone marrow–derived osteogenic colony formation. (A) Representative dishes of ALP
þ or total colonies formed by
wild-typeandSmurf1
 / bonemarrowstromal cells.Colony-forming unit(CFU)assayswereperformedasdescribedin‘‘MaterialsandMethods.’’CFU-ALP,
the CFU assays stained with BCIP/NBT, showed ALP
þ colonies; CFU-total¼the CFU assays counterstained with eosin. (B) Representative microscopic ( 4)
imagesofwild-typeorSmurf1
 / coloniesstainedwithBCIP/NBTandeosin.(C)StatisticalanalysesofCFUassays.Thenumberofcolonies(eachcontaining
a minimum of 20 cells) was calculated after the total number of Smurf1
 /  colonies was set to 100%. Bars represent mean SD of three dishes per
genotype.
 p<.05 versus wild-type cells, n¼3. (D) Bone marrow stromal cells from wild-type and Smurf1
 /  mice were cultured in osteoblast
differentiation medium, and ALP mRNA levels were examined at different time points using quantitative RT-PCR.
 p<.05 versus wild-type cells, n¼3. (E)
C2C12 cells were treated with BMP2 (100ng/mL) with indicated time. Osteocalcin, JunB, and Runx2 mRNA levels were examined using real-time qPCR.
 p<.05 versus time 0, n¼3.
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the JunB-YF protein levels were unchanged in the same
experiment (Fig. 3E), suggesting that a direct interaction
between Smurf1 and JunB is required for Smurf1-induced JunB
degradation.
Since Smurf1 specifically interacts with JunB and induces its
degradation, we reasoned that JunB can be polyubiquitinated
when Smurf1 is present. To demonstrate that Smurf1-mediated
JunB degradation is through the ubiquitin-proteasome system,
we examined whether proteasome inhibitor MG132 blocks JunB
degradation. As expected, after treatment with MG132 for
4hours, the degradation of JunB was prevented (Fig. 3F),
indicatingthatSmurf1-inducedJunBdegradationisproteasome-
dependent. To demonstrate that Smurf1 promotes ubiquitination
Fig. 2. Smurf1 induces JunB degradation in vivo and in vitro. (A, B) JunB protein level was increased in the primary calvarial (A) and bone marrow stromal
cells (B)o fSmurf1
 /  mice compared with that of wild-type mice (n¼4). c-Jun protein level also was determined by Western blot analysis. (C) Real-time
qPCR data showed that JunB mRNA level underwent no significant changes in the bone marrow stromal cells of Smurf1
 /  and wild-type mice (n¼3).
(D) Smurf1 expression decreases JunB protein levels in a dose-dependent manner (n¼5). HEK293T cells were transfected with Flag-JunB and Myc-Smurf1
plasmids. Myc-Smurf1 was added in different amounts. Myc-Smurf1 (C710A) is a mutated Smurf1 in which an active-site cysteine in its catalytic domain is
convertedintoalaninetoabolishitsactivityasanubiquitinligase.(E,F)HEK293TcellstransfectedwithMyc-Smurf1andFlag-JunBweretreatedwithprotein
translationinhibitorcycloheximide(80mg/mL)forindicatedtimeandsubjectedtoWesternblotanalysisofJunBproteinlevelstodeterminethehalf-lifeof
JunB proteins in the presence or absence of Smurf1 overexpression in HEK293T cells (n¼3). Both Western blot (E) and its quantification ( F) are shown.
1250 Journal of Bone and Mineral Research ZHAO ET AL.of JunB protein, we performed a ubiquitination assay. 293T cells
were cotransfected with Myc-Smurf1, HA-Ubiquitin, Flag-JunB,o r
Flag-JunB-YF mutant and treated with MG132. IP, using an anti-
Flag antibody, followed by immunoblotting with an anti-HA
antibody, showed that the wilt-type JunB, but not the JunB-YF
mutant, resulted in polyubiquitination (Fig. 3G).
Smurf1 has a negative effect on the proliferation of bone
marrow mesenchymal stem cells
It has been reported that JunB plays an important role in
osteoblasts. Calvarial preosteoblasts and bone marrow stromal
cells from JunB-deficient mice have decreased proliferation and
Fig. 3. Smurf1 interacts with JunB through a PY motif and induces its ubiquitination and degradation. (A) GST-Smurf1 directly interacts with JunB protein.
Invitro–translatedJunBproteinwascopurifiedwithGST-Smurf1inaGSTpull-downassay(n¼3).(B)JunB-Smurf1interactioninmesenchymalC2C12cells.
Smurf1 was identified in the immunoprecipitates by anti-JunB antibodies (n¼3). (C) A diagram showing a YF mutation in the PY motif of JunB that was
generatedtoexamineifthePYmotifisrequiredbySmurf1-inducedJunBdegradation.(D)Wild-typeJunBproteininteractswithSmurf1,whereasJunB(YF)
mutant cannot (n¼3). HEK293T cells were transfected with Myc-Smurf1-C710A and Flag-JunB or Flag-JunB-YF. IP assays were carried out using anti-Flag
antibodies, andimmunoprecipitatesweresubjectedto Westernblot usinganti-Mycantibodies; whole-cell lysatesalso wereexaminedto ensurethat both
JunB and Smurf1 were expressed. (E) Smurf1 overexpression could not decrease the protein level of JunB-YF (n¼4). HEK293T cells were transfected with
plasmids as indicated. ( F) Proteasome inhibitor MG132 rescued JunB protein from Smurf1-induced degradation (n¼3). HEK293T cells were transfected
with plasmids as shown. Cells transfected with Myc-Smurf1 and Flag-JunB were treated with MG132 (10mM) for 4hours before being harvested
and subjected to Western blot analysis. (G) JunB ubiquitination assay (n¼3). 293T cells transfected with HA-ubiquitin, Myc-Smurf1, and Flag-JunB or Flag-
JunB-YF were treated with MG132 for 4hours before harvesting, and polyubiquitinated JunB was immunoprecipitated by anti-Flag and immunoblotted
with anti-HA.
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(20,21) Since our Western results demonstrated
that both calvarial preosteoblasts and bone marrow stromal cells
of Smurf1
 /  mice have accumulated JunB proteins, it would be
interesting to examine whether these cells have increased
proliferation and elevated cell-cycle protein such as cyclin D1, a
positive regulator of cell proliferation. Thus we performed
Western blot to examine cyclin D1 protein levels in calvarial
preosteoblasts and bone marrow stromal cells and found that
these cells had higher cyclin D1 protein levels than wild-type
cells (Fig. 4A). Next, we examined the mRNA expression of
cyclin D1 and found that cyclin D1 transcription was induced at a
higher level in Smurf1
 /  marrow stromal cells that also have
elevated JunB protein (Fig. 4B). In fact, it was reported that
cyclin D1 promoter contains binding sites of AP-1 factors,
through which JunB regulates cyclin D1 expression in fibro-
blasts
(22,23) and in mesenchymal C2C12 cells (Supplemental
Fig. 4. Smurf1 negatively regulates MSC proliferation. (A) Western blot results showed that the cyclin D1 protein level was increased in the primary
calvarial cells or in the marrow stromal cells of Smurf1
 /  mice compared with wild-type mice (n¼3). (B) Real-time qPCR data showed that the cyclin D1
mRNA level was increased in marrow stromal cells of Smurf1
 /  mice.
 p<.05 versus wild-type cells, n¼3. (C) C3H10T1/2 mesenchymal stem cells were
transfected with cyclin D1 reporter and different doses of JunB overexpression plasmids. Luciferase activities showed that cyclin D1 promoter was induced
by JunB expression in a dose-dependent manner.
 p<.05 versus pGL3-Luc, n¼3. (D) C2C12 myoblast/osteoblast progenitor cells were transfected with
cyclin D1 reporter and different doses of JunB overexpression plasmids. Luciferase activities showed that cyclin D1 promoter was induced by JunB
expressionin a dose-dependentmanner.
 p<.05 versuspGL3-Luc, n¼3. (E) The numbersofSmurf1
 /  bonemarrowstromal cellswere higherthan those
of wild-type cells after 7 days of culture in 12-well plates.
 p<.05 versus wild-type cells, n¼4. ( F) Cell proliferation rates were increased in Smurf1
 / 
BMSCs. Thus 3 10
5 or 9 10
5 BMSCs per well were seeded into 96-well plate, and cell proliferation was examined using a colorimetric assay.
 p<.05
versus wild-type cells, n¼4. (G) Smurf1
 /  CD45
  MSCs have a higher proliferation rate than wild-type cells. Bone marrow cells were stained with APC-
CD45 and FITC–anti-BrdU after in vivo labeling of BrdU by i.p. injection. CD45
  and BrdU
þ populations of wild-type and Smurf1
 /  cells were analyzed
(n¼3).
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we transfected the cyclin D1-Luc reporter construct into the
mesenchymal stem cell line C3H10T1/2 cells and studied
whether JunB introduction enhances the cyclin D1 promoter
reporter activities. As Fig. 4C shows, cyclin D1 promoter
responded to JunB expression in a dose-dependent manner,
suggesting that JunB promotes cyclin D1 expression at a
transcriptional level in MSCs. Similar results also were obtained
when C2C12 cells were used (Fig. 4D), indicating that increased
osteogenic colonies in the Smurf1
 /  mesenchymal cells shown
in Fig. 1A–C may be due to increased proliferation. To test this,
we decided to examine the proliferation in MSCs in vitro and in
vivo. We counted the cell numbers of bone marrow stromal cells
cultured in vitro and found that the number of Smurf1
 /  cells
was significantly higher than that of wild-type cells (Fig. 4E),
although the bone marrow cells were plated in the same
number. Cell proliferation assays also confirmed an increased
proliferation rate of Smurf1
 /  bone marrow stromal cells
(Fig. 4F). We labeled Smurf1
 /  bone marrow cells with BrdU by
i.p. injection and stained them with a combination of APC–anti-
CD45 and FITC–anti-BrdU and then performed FACS analyses to
assess the percentage of BrdU
þ cells within the CD45
  cell
population. Murine bone marrow MSCs, characterized as
lineage
 /CD45
 /CD105
þ, have been used for osteoblast
differentiation.
(24) We demonstrate that CD45
  cells isolated
from adult mouse marrow are hematopoietic lineage
 , and half
of them are CD105
þ after culturing in vitro (Supplemental Fig. 4).
Furthermore, CD45
  cells can give rise to osteoblasts and
adipocytes, whereas CD45
þ cells cannot (data not shown). Based
on this fact, we can gate out the CD45
þ hematopoietic lineage
cells from bone marrow cells and analyze the CD45
  MSC
population specifically. Flow cytometric results demonstrated
that BrdU
þ cells comprised 76.42% of CD45
  cells in Smurf1
 / 
MSCs and were significantly more enriched than those (26.83%)
in wild-type MSCs (Fig. 4G), suggesting that Smurf1 deficiency
positively regulated MSC proliferation.
JunB degradation induced by Smurf1 also negatively
regulates MSC differentiation into osteoblasts
An increase in osteogenic potential and JunB protein levels in
Smurf1
 /  bone marrow stromal cells suggests a positive
correlation between osteoblast differentiation and JunB expres-
sion levels. To confirm this, we overexpressed JunB protein in
C2C12 cells, a myoblast/osteoblast precursor cell line, by
retrovirally infecting cells with JunB-expressing retrovirus. As
the JunB protein level increased in C2C12 cells (Fig. 5A), ALP
activity also was strikingly induced in these cells (Fig. 5B),
suggesting that enhanced JunB protein level increased
osteoblast differentiation potential of the progenitor cells. This
result is consistent with the studies performed using Smurf1
 / 
cells. Next, to further confirm that JunB is responsible for the
increased osteoblast differentiation potential of Smurf1
 /  cells,
we preformed JunB RNAi experiments to investigate whether
JunB knockdown can restore increased osteoblast differentiation
of Smurf1
 /  cells with or without BMP2 stimulation. We
isolated calvarial preosteoblasts and purified the CD45
  MSC
population from bone marrow stromal cells using CD45
antibody–conjugated magnetic beads and transfected these
cells with JunB siRNA. Our RNAi experiments achieved
considerable downregulation of JunB expression: Most samples
had over 50% decrease of JunB mRNA or protein compared with
those transfected with control siRNA (Fig. 5C, D, F). It should be
noted that JunB mRNA expression in wild-type and Smurf1
 / 
cells (Fig. 5D, F) were not similar, as we had observed in Fig. 2C.
This discrepancy could be caused by a longer culture of cells to
reach a confluence of greater than 90% before siRNA
transfection and to minimize the deleterious effects of siRNA
transfection. Such a long-term culture could result in MSC
differentiation, and Smurf1
 /  cells had greater potential to
differentiate into osteoblasts; thus JunB mRNA expression was
induced in a greater degree in Smurf1
 /  cells, as Fig. 1E
suggested. Next, we examined ALP activity or ALP mRNA
expression, as well as osteocalcin mRNA expression by RT-PCR to
study if osteoblast differentiation was affected in those cells with
decreased JunB protein levels. We found that JunB siRNA
significantly decreased ALP mRNA expression or protein activity
by 50% to 60% under basal and BMP2-stimulated conditions in
both calvarial preosteoblasts and CD45
  MSCs of wild-type mice
(Fig. 5E, G). Importantly, JunB downregulation by siRNA restored
ALPexpressionoractivityinbothpreosteoblasts andCD45
 MSC
of Smurf1
 /  mice to a level similar with that of wild-type mice
(Fig. 5E, G), suggesting that Smurf1 deficiency–enhanced
osteoblast differentiation of MSCs is JunB-dependent. Examina-
tion of the osteocalcin mRNA level in CD45
  MSCs (Fig. 5H)
further confirmed that JunB plays a positive role in osteoblast
differentiation, which may significantly contribute to Smurf1
deficiency–promoted bone formation.
Discussion
Using bone marrow stromal cells and purified bone marrow
MSCs derived from adult Smurf1
 /  mice, we demonstrated that
Smurf1-deficient cells have increased CFU-ALP colony formation
and osteoblast marker gene expression. For the underlying
mechanism, we demonstrated that Smurf1 regulates the protein
stability of JunB, an immediate-early gene induced by BMP2.
Smurf1 binds directly to JunB and promotes its ubiquitination
and proteasomal degradation. Smurf1 deficiency affects both
differentiation and proliferation of bone marrow MSCs, which is
rescued by JunB knockdown. Thus the inhibitory effect of Smurf1
on osteoblast function occurs at the stem cell level through the
regulation of JunB protein degradation.
JunB is a member of the AP-1 family and is an immediate-early
geneinducedby BMP2inC2C12 myoblast/osteoblast progenitor
cells.
(19) Loss of JunB affects vasculogenic and angiogenic
processes in the developing placenta,
(25) causing embryonic
lethality,whichcanberescuedbyintercrossingjunB
þ/ withUbi-
junB transgenic mice or crossing junB-floxed mice with mice
carring the MORE-Cre knock-in allele. Both these JunB-deficient
mice are osteopenic. Osteoblasts and precursors derived from
bone marrow stromal cells or calvarial cells have reduced
proliferation, marker-gene expression, and mineralized bone
nodule formation,
(20,21) indicating that JunB plays a critical,
positive role in osteoblast differentiation, proliferation, and
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negatively regulated by ubiquitin ligase Smurf1 in MSC
proliferation and differentiation into osteoblasts, confirming
that JunB functions as an important transcriptional factor in the
early stages of bone formation.
Cell proliferation is controlled by many factors, including
cyclins. Cyclin D1 is a target of several bone anabolic agents in
preosteoblasts.
(26,27) For instance, parathyroid hormone–related
protein (PTHrP) upregulates cyclin D1 transcription. Finding of
JunB stimulates cyclin D1 promoter activity by directly binding
the AP-1 response element of the cyclin D1 promoter in MSCs,
indicating that JunB contributes to the increase in cell
proliferation through cyclin D1. However, we cannot exclude
other mechanisms because JunB also regulates the expression of
other cellcyclin mediators.
(28) Nevertheless, thesefindingsreveal
a novel function of ubiquitin ligase Smurf1 in MSC proliferation
and differentiation.
Smurf1 is known to control bone mass in aged mice.
Overexpression of Smurf1 decreases the protein levels of Smad1
and -5, Runx2, and the BMP receptor, which are involved in
Fig. 5. Smurf1-inducedJunBdegradationhasanegativeimpactonosteoblastdifferentiationofMSCs.(A)WesternblotshowedthattheJunBproteinlevel
was increased in C2C12 cells infected with JunB-overexpressing retrovirus (n¼3). (B) Enhanced ALP activity by JunB overexpression in C2C12 myoblast/
osteoblast progenitor cells shown by ALP staining of control or JunB-overexpressing cells on BMP2 treatment at the doses indicated (n¼3). (C, D) JunB
knockdown by siRNA was confirmed by Western blotting (C) or RT qPCR (D).
 p<.05 versus wild-type cellsþcontrol siRNA, n¼3. Calvarial cells of wild-
type and Smurf1
 /  mice were isolatedand transfected with JunB siRNA or control siRNA. Cells were cultured in osteoblast differentiation medium with or
without BMP2. (E) ALP activity of the calvarial cells transfected with siRNAs was measured to evaluate whether JunB knockdown restored increased
osteogenic differentiation in Smurf1
 /  cells.
 p<.05 versus wild-type cellsþcontrol siRNA, n¼3. (F–H) CD45
  MSCs were isolated from in vitro–cultured
bone marrow stromal cells of wild-type and Smurf1
 /  mice, transfected with JunB siRNA or control siRNA and then cultured in osteoblast differentiation
medium with or without BMP2. JunB ( F), ALP (G) and osteocalcin (H) mRNA levels were measured by real-time qPCR.
 p<.05 versus wild-type
cellsþcontrol siRNA, n¼3.
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from Smurf1
 /  mice have normal BMP signaling response,
arguing against these BMP signal proteins as the endogenous
targets for Smurf1 in these cells.
(13) We have demonstrated
that Smurf1-induced degradation of BMP signal proteins
plays a more important role in inflammatory osteoblast
inhibition than in normal bone remodeling.
(14) JunB is an early
response gene for BMP and regulates both cell proliferation
and differentiation, whereas Smad1 and -5 and Runx2 mainly
affect osteoblast differentiation. Thus, although Smurf1 also
ubiquitinates proteins other than JunB, Smurf1-induced changes
in JunB protein levels in MSCs and osteoblast precursors
likely contribute to increased CFU colony-forming capacity of
Smurf1
 /  cells.
JunB ubiquitination and proteasome degradation have been
reported in activated T cells by E3 ligase Itch.
(29–31) Smurf1-
mediated JunB ubiquitination and degradation represent
another regulatory mechanism controlling JunB function in
cells. Although Smurf1 and Itch both promote JunB degradation,
they clearly have different effects on bone cells. Smurf1
 /  mice
have an age-related increase in bone mass and osteoblast
function.
(13,14) In contrast, while itch
 /  mice have decreased
bone volume (our preliminary observation), bone quality or
osteoblast function in itch
 /  mice has not been investigated.
Furthermore, the Itch E3 ligase activity is regulated by
phosphorylation. After T cell receptor engagement, Itch under-
goes JNK1-mediated phosphorylation that causes configuration
changes that greatly enhance its enzymatic activity.
(29,30) We
have examined the effect of various kinase inhibitors, including
Erk, JNK, p38, and AKT, on Smurf1-mediated JunB degradation
and found that they have no influence (Supplemental Fig. 2).
Interestingly, Smurf1 is restricted to induce the degradation
of JunB but not c-Jun proteins in MCSs, whereas Itch was
demonstrated to ubiquitinate both c-Jun and JunB proteins in T
cells.
(29) These results suggest that a specific regulation of JunB
ubiquitination and degradation induced by HECT-type ubiquitin
ligasesoccurs in the MSCs to ensure that JunB functions properly
in bone-forming process.
Together our results represent a novel facet of bone
homeostasis that correlates AP-1 factor and HECT-type ubiquitin
ligase regulating MSC proliferation and differentiation, giving
clues for developing new therapeutic strategies to prevent
age-dependent bone loss.
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